---
$id: https://graph.org.ai/products/commodity/51152029
$type: Product
source: UNSPSC
code: "51152029"
title: "Fazadinium bromide"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fazadinium bromide

**UNSPSC Code**: 51152029
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nicotinic antagonist with the molecular formula C28H24N6.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8WV5538LFK, chemically known as 1,1-azobis(3-methyl-2-phenylimidazo(1,2-a)pyridinium) dibromide but generally known as fazadinium bromide, which bears US NIH Compound Identifier 5489112. European Medicines Agency schedules Fazadinium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07516MIG. The term FAZADINIUM BROMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules fazadinium bromide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule fazadinium bromide under HS 29339990 and SITC 51577. As of Q4 2014, FAZADINIUM BROMIDE remains the US FDA Preferred Term for this commodity. Fazadinium bromide bears US NLM identifiers UMLS ID C0015707 and NCI Concept Code C80530. SMILES: Br.Br.N1(/N=N/n2c(C3CCCCC3)c([n]3c2cccc3)C)C(C2CCCCC2)C([n]2c1cccc2)C.

